β2-adrenergic receptor polymorphisms affect response to treatment in children with severe asthma exacerbations

Chest

Volumn 135, Issue 5, 2009, Pages 1186-1192

  Carroll, Christopher L ^a   Stoltz, Petronella ^a   Schramm, Craig M ^a   Zucker, Aaron R ^a  

^a Farmington   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ARGININE; BETA 2 ADRENERGIC RECEPTOR; GLYCINE; METHYLPREDNISOLONE; SALBUTAMOL; TERBUTALINE; BETA ADRENERGIC RECEPTOR STIMULATING AGENT; GLUTAMIC ACID; GLUTAMINE;

ADULT; ALLELE; ARTICLE; CHILD; CHILD HOSPITALIZATION; COHORT ANALYSIS; DISEASE EXACERBATION; DRUG MEGADOSE; FEMALE; GENETIC ANALYSIS; GENETIC ASSOCIATION; GENETIC VARIABILITY; GENOTYPE; HETEROZYGOSITY; HOMOZYGOSITY; HUMAN; INTENSIVE CARE; LENGTH OF STAY; MAJOR CLINICAL STUDY; MALE; MILD INTERMITTENT ASTHMA; MILD PERSISTENT ASTHMA; MODERATE PERSISTENT ASTHMA; NEBULIZATION; OBESITY; OXYGEN SATURATION; PRESCHOOL CHILD; PRIORITY JOURNAL; SALIVA ANALYSIS; SCHOOL CHILD; SEVERE PERSISTENT ASTHMA; SINGLE NUCLEOTIDE POLYMORPHISM; TREATMENT DURATION; TREATMENT RESPONSE; ADOLESCENT; ASTHMA; DISEASE COURSE; GENETICS; HOSPITALIZATION; PATHOLOGY; RETROSPECTIVE STUDY; TREATMENT OUTCOME;

ADOLESCENT; ADRENERGIC BETA-AGONISTS; ALBUTEROL; ASTHMA; CHILD; CHILD, PRESCHOOL; DISEASE PROGRESSION; FEMALE; GENOTYPE; GLUTAMIC ACID; GLUTAMINE; GLYCINE; HUMANS; LENGTH OF STAY; MALE; POLYMORPHISM, SINGLE NUCLEOTIDE; RECEPTORS, ADRENERGIC, BETA-2; RETROSPECTIVE STUDIES; SEVERITY OF ILLNESS INDEX; TREATMENT OUTCOME;

EID: 65949105914     PISSN: 00123692     EISSN: 19313543     Source Type: Journal    
DOI: 10.1378/chest.08-2041     Document Type: Article

References (32)

1. McFadden ER Jr. Acute severe asthma. Am J Respir Crit Care Med 2003; 168:740-759 (Pubitemid 37188297)
2. Romagnoli M, Caramori G, Braccioni F, et al. Near-fatal asthma phenotype in the ENFUMOSA cohort. Clin Exp Allergy 2007; 37:552-557 (Pubitemid 46537743)
3. Pendergraft TB, Stanford RH, Beasley R, et al. Rates and characteristics of intensive care unit admissions and intubations among asthma-related hospitalizations. Ann Allergy Asthma Immunol 2004; 93:29-35 (Pubitemid 39243133)
4. McCormick MC, Kass B, Elixhauser A, et al. Annual report on access to and utilization of health care for children and youth in the United States: 1999. Pediatrics 2000; 105:219-230
5. DeFrances CJ, Podgornik MN. 2004 National Hospital Discharge Survey. Adv Data 2006; 371:1-19
6. Werner HA. Status asthmaticus in children. Chest 2001; 119:1913-1929
7. Baren JM, Zorc JJ. Contemporary approach to the emergency department management of pediatric asthma. Emerg Med Clin North Am 2002; 20:115-138 (Pubitemid 34094882)
8. Smith SR, Strunk RC. Acute asthma in the pediatric emergency department. Emerg Med 1999; 46:1145-1165
9. 2-adrenergic receptor in normal and asthmatic subjects. Am J Respir Cell Mol Biol 1993; 8:334-339
10. 2-adrenoceptor haplotype in patients with asthma. Am J Respir Crit Care Med 2005; 172:700-703
11. 2-adrenoceptors in asthmatic patients. Chest 1999; 115:324-328
12. 2-adrenergic receptor haplotypes alter receptor expression and predict in vivo responsiveness. Proc Natl Acad Sci U S A 2000; 97:10483-10488
13. 2-adrenergic receptor on the response to regular use of albuterol in asthma. Am J Respir Crit Care Med 2000; 162:75-80
14. 2-adrenoceptor polymorphism. Thorax 2000; 55:762-767
15. Israel E, Chinchilli VM, Ford JG, et al. Use of regularly scheduled albuterol treatment in asthma: genotype-stratified, randomised, placebo-controlled cross-over trial. Lancet 2004; 364:1505-1512 (Pubitemid 39410416)
16. 2 adrenoceptor genotype predisposes to exacerbations in young asthmatics taking regular salmeterol. Thorax 2006; 61:940-944
17. 2-adrenergic receptor polymorphisms with asthma phenotypes. J Allergy Clin Immunol 2005; 115:963-972
18. 2-adrenoceptor and response to albuterol in children with and without a history of wheezing. J Clin Invest 1997; 100:3184-3188
19. 2-adrenergic receptor polymorphisms affect airway responsiveness to salbutamol in asthmatics. J Asthma 1999; 36:583-590
20. 2-adrenergic receptor on albuterol bronchodilator pharmacodynamics. Clin Pharmacol Ther 1999; 65:519-525
21. 2-adrenoceptor gene polymorphisms. Respir Med 2006; 100:1072-1078
22. 2- adrenoceptor polymorphism predisposes to bronchoprotective subsensitivity in patients treated with formoterol and salmeterol. Br J Clin Pharmacol 2004; 57:68-75
23. 2-agonists in children with acute asthma. J Asthma 2008; 45:383-388
24. Carroll CL, Sekaran AK, Lerer TJ, et al. A modified pulmonary index score with predictive value for pediatric asthma exacerbations. Ann Allergy Asthma Immunol 2005; 94:355-359 (Pubitemid 40396581)
25. Carroll CL, Schramm CM. Protocol-based titration of intravenous terbutaline decreases length of stay in pediatric status asthmaticus. Pediatr Pulmonol 2006; 41:350-356
26. 2-adrenergic receptor agonist therapy: defining a novel phenotype in pediatric status asthmaticus. Pediatr Pulmonol 2008; 43:627-633
27. National Asthma Education and Prevention Program. Expert panel report 3: guidelines for the diagnosis and management of asthma. Bethesda, MD: National Heart, Lung and Blood Institute, 2007; NIH publication No. 07-4051
28. Kuczmarski RJ, Ogden CL, Grummer-Strawn LM, et al. CDC growth charts: United States. Adv Data 2000; 1-27
29. 2- adrenergic receptor polymorphisms in African-American children with status asthmaticus. Pediatr Crit Care 2006; 7:15-18
30. 2-adrenergic receptor polymorphisms: pharmacogenetic response to bronchodilator among African American asthmatics. Hum Genet 2006; 119: 547-557
31. 2- adrenoceptor polymorphisms at codon 16 and 27 to persistence of asthma symptoms after the onset of puberty. Chest 2005; 128:609-617
32. Choudhry S, Ung N, Avilia PC, et al. Pharmacogenetic differences in response to albuterol between Puerto Ricans and Mexicans with asthma. Am J Respir Crit Care Med 2005; 171:563-570